Dr. Jana Ivanidze, MD, PHD
What this data tells you about Dr. Ivanidze
Dr. Jana Ivanidze is a radiation oncology specialist in New York, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Ivanidze performed 10,674 Medicare services across 774 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ivanidze received a total of $5,877 from 6 pharmaceutical and/or device companies across 17 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ivanidze is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| MRI contrast dye injection (gadobutrol) | 8,679 | $0 | $2 |
| Gallium Ga-68 dotatate diagnostic injection A diagnostic injection of Gallium Ga-68 dotatate used for imaging. The dose specified is 0.1 millicurie. |
1,328 | $49 | $167 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 125 | $413 | $1,665 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
119 | $304 | $7,530 |
| Brain nuclear medicine study with metabolic evaluation A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level. |
118 | $1,446 | $8,110 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
112 | $45 | $1,400 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
110 | $38 | $700 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
44 | $1,483 | $10,298 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
23 | $186 | $4,281 |
| Nuclear medicine study with CT scan A nuclear medicine imaging test performed on a specific body area combined with a CT scan. |
16 | $1,507 | $7,789 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
The majority of payments (69%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ivanidze is a mixed practice specialist, with above-average Medicare volume (top 16% in NY), with consulting-driven industry engagement in the top 13% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ivanidze experienced with mri contrast dye injection (gadobutrol)?
Does Dr. Ivanidze receive payments from pharmaceutical companies?
How do Dr. Ivanidze's costs compare to other radiation oncologists in New York?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology